Alphatec Holdings (ATEC) Preferred Stock Liabilities (2011 - 2026)
Alphatec Holdings' (ATEC) quarterly Preferred Stock Liabilities came in at $23.6 million in Q2 2026, little changed year-over-year from $23.6 million in Q2 2025, and little changed quarter-over-quarter from $23.6 million in Q1 2026.
Analysis
Alphatec Holdings (ATEC) Preferred Stock Liabilities (2011 - 2026) Analysis & Trends
Alphatec Holdings has disclosed Preferred Stock Liabilities across 16 years of filings, most recently posting $23.6 million for Q2 2026.
- In Q2 2026, Preferred Stock Liabilities changed 0.0% year-over-year to $23.6 million; the TTM figure through Jun 2026 stood at $23.6 million (changed 0.0% YoY), while the FY2025 annual figure was $23.6 million, changed 0.0% from the prior year.
- Preferred Stock Liabilities came in at $23.6 million for Q2 2026 at Alphatec Holdings, roughly flat from $23.6 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $23.6 million in Q1 2022 to a low of $23.6 million in Q1 2022.
- Average Preferred Stock Liabilities over 5 years is $23.6 million, with a median of $23.6 million recorded in 2022.
- The largest YoY upside for Preferred Stock Liabilities was 0.0% in 2022 against a maximum downside of 82.1% in 2022.
- Over 5 years, Preferred Stock Liabilities stood at $23.6 million in 2022, then changed by 0.0% to $23.6 million in 2023, then changed by 0.0% to $23.6 million in 2024, then changed by 0.0% to $23.6 million in 2025, then changed by 0.0% to $23.6 million in 2026.
- Per Business Quant data, the three most recent Preferred Stock Liabilities figures were $23.6 million in Q2 2026, $23.6 million in Q1 2026, and $23.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | Alphatec Holdings | 1.38 Bn | 1.26 Bn | 154.10 Mn | 23.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.60 Mn |
| Mar 31, 2026 | 23.60 Mn |
| Dec 31, 2025 | 23.60 Mn |
| Sep 30, 2025 | 23.60 Mn |
| Jun 30, 2025 | 23.60 Mn |
| Mar 31, 2025 | 23.60 Mn |
| Dec 31, 2024 | 23.60 Mn |
| Sep 30, 2024 | 23.60 Mn |
| Jun 30, 2024 | 23.60 Mn |
| Mar 31, 2024 | 23.60 Mn |
| Dec 31, 2023 | 23.60 Mn |
| Sep 30, 2023 | 23.60 Mn |
| Jun 30, 2023 | 23.60 Mn |
| Mar 31, 2023 | 23.60 Mn |
| Dec 31, 2022 | 23.60 Mn |
| Sep 30, 2022 | 23.60 Mn |
| Jun 30, 2022 | 23.60 Mn |
| Mar 31, 2022 | 23.60 Mn |
| Dec 31, 2021 | 23.60 Mn |
| Sep 30, 2021 | 23.60 Mn |